0001209191-23-026798.txt : 20230503
0001209191-23-026798.hdr.sgml : 20230503
20230503084007
ACCESSION NUMBER: 0001209191-23-026798
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bolte Axel
CENTRAL INDEX KEY: 0001579247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39397
FILM NUMBER: 23881875
MAIL ADDRESS:
STREET 1: PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inozyme Pharma, Inc.
CENTRAL INDEX KEY: 0001693011
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475129768
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-330-4340
MAIL ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Inozyme Pharma, LLC
DATE OF NAME CHANGE: 20161222
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-01
0
0001693011
Inozyme Pharma, Inc.
INZY
0001579247
Bolte Axel
C/O INOZYME PHARMA, INC.
321 SUMMER STREET SUITE 400
BOSTON
MA
02210
1
0
0
0
0
Stock option (right to buy)
5.81
2023-05-01
4
A
0
100000
0.00
A
2033-04-30
Common Stock
100000
100000
D
The option was granted on May 1, 2023. The shares underlying the option are scheduled to vest in equal monthly installments from June 1, 2023 through May 1, 2025, provided Mr. Bolte is providing services to the Company on such dates.
/s/ Sanjay Subramanian, as attorney-in-fact for Axel Bolte
2023-05-03